Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BPMC - Blueprint Medicines  GAAP EPS of -$5.40 misses by $4.25 revenue of $107M beats by $2.86M

BPMC - Blueprint Medicines  GAAP EPS of -$5.40 misses by $4.25 revenue of $107M beats by $2.86M

Blueprint Medicines Corporation
Blueprint Medicines  press release (NASDAQ:BPMC): Q4 GAAP EPS of -$5.40 misses by $4.25. Revenue of $107M (+213.7% Y/Y) beats by $2.86M. Blueprint Medicines today announced it anticipates approximately $180M to $200M in total revenues in 2022, including approximately $115M to $130M in AYVAKIT net product revenues.

For further details see:

Blueprint Medicines  GAAP EPS of -$5.40 misses by $4.25, revenue of $107M beats by $2.86M
Stock Information
Company Name: Blueprint Medicines Corporation
Stock Symbol: BPMC
Market: NASDAQ
Website: blueprintmedicines.com
Menu
BPMC BPMC Quote BPMC Short BPMC News BPMC Articles BPMC Message Board
Get BPMC Alerts

News, Short Squeeze, Breakout and More Instantly...